Periodontal Disease
Conditions
Interventions
To evaluate the therapeutic effect of 2.5% melaleuca gel in the treatment of chronic periodontal disease in systemically healthy patients by comparing it with the therapeutic effect of 1% chlorhexidin
Other
D02.078.370.141.100
HP4.018.189.077
Sponsors
Centro Universitário Cesmac
Centro Universitário Cesmac
Eligibility
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients systemically healthy, older than 18 years and younger than 60 years of age, able to read and sign the WICF and diagnosed with chronic periodontal disease.
Exclusion criteria
Exclusion criteria: Patients with any pathology that negatively influence tissue healing (eg diabetes mellitus), pregnant and lactating, allergic to adjuvants that are used in the research, and smokers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The therapeutic effect of 2.5% melaleuca gel in the treatment of chronic periodontal disease in systemically healthy patients is equal to or greater than 1% Chlorhexidine.;It is intended to evaluate the therapeutic effect of 2.5% melaleuca gel in the treatment of chronic periodontal disease in systemically healthy patients through its comparison with the therapeutic effect of 1% chlorhexidine gel | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effects of 1% chlorhexidine and 2.5% melaleuca gel on pouch irrigation in the treatment of chronic peridontitis in systemically healthy patients;To evaluate the incidence of adverse effects arising from the use of chemical adjuvants (chlorhexidine 1% and Melaleuca 2.5%) in the form of gel for irrigation of periodontal pockets in a single dose | — |
Countries
Brazil
Contacts
Public ContactRenata Pereira
Centro Universitário Cesmac
Outcome results
None listed